×
About 6,228 results

ALLMedicine™ Meningioma Center

Research & Reviews  2,394 results

Clipping-test of a Radiculo-medullary artery during resection of a dorsal spinal mening...
https://doi.org/10.1016/j.wneu.2022.05.005
World Neurosurgery; Barrey CY, Baassiri W et. al.

May 14th, 2022 - Clipping-test of a Radiculo-medullary artery during resection of a dorsal spinal meningioma.|2022|Barrey CY,Baassiri W,Vandenbulcke A,|

Primary Extradural Ectopic Orbital Meningioma in a Child.
https://doi.org/10.1097/IOP.0000000000002200
Ophthalmic Plastic and Reconstructive Surgery; Tynan D, Ng J et. al.

May 14th, 2022 - The authors describe a rare case of primary extradural ectopic meningioma of the orbit in a 13-year-old female managed with surgical excision, adding to the very limited literature of this diagnosis in children. This is the second case to show a r...

Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meni...
https://doi.org/10.1227/neu.0000000000002026
Neurosurgery Slavik H, Balik V et. al.

May 14th, 2022 - Meningioma is the most common primary central nervous system neoplasm, accounting for about a third of all brain tumors. Because their growth rates and prognosis cannot be accurately estimated, biomarkers that enable prediction of their biological...

Diagnostic potential of extracellular vesicles in meningioma patients.
https://doi.org/10.1093/neuonc/noac127
Neuro-oncology Ricklefs FL, Maire CL et. al.

May 14th, 2022 - Extracellular vesicles (EVs) play an important role in cell-cell communication, and tumor-derived EVs circulating in patient blood can serve as biomarkers. Here, we investigated the potential role of plasma EVs in meningioma patients for tumor det...

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabi...
https://doi.org/10.1038/s41588-022-01061-8 10.3171/2015.6.JNS15591 10.1016/j.celrep.2018.03.013 10.1016/S1470-2045(17)30155-9 10.1007/s00401-017-1678-x 10.1093/neuonc/noz061 10.1038/ncomms14433 10.1038/s41586-021-03850-3 10.1093/bioinformatics/btu049 10.1186/1750-1172-4-16 10.1126/science.1233009 10.1038/ng.2526 10.1038/s41467-017-00174-7 10.1007/s00401-017-1715-9 10.1007/s00401-013-1093-x 10.1007/s00401-013-1187-5 10.1186/s40478-020-00994-7 10.1083/jcb.200703010 10.1083/jcb.201503081 10.1016/j.cell.2010.01.029 10.1038/s41467-020-18582-7 10.1227/00006123-199009000-00008 10.1016/j.cell.2014.09.029 10.1038/s41592-018-0048-5 10.3171/jns.1995.82.5.0864 10.1016/j.cell.2017.03.022 10.1016/S0021-9258(19)47378-X 10.1016/S0021-9258(18)31504-7 10.1128/MCB.00146-10 10.1172/JCI96636 10.1186/s13059-017-1349-1 10.1093/bioinformatics/bty011 10.1093/bioinformatics/bty316 10.1016/j.cell.2017.10.001 10.1038/s41587-019-0114-2 10.1038/s41467-018-03959-6 10.1002/jcp.20106 10.1101/gad.303776.117 10.1016/j.matbio.2010.08.001 10.1038/nature14432 10.1084/jem.20170391 10.1038/s41586-019-1419-5 10.1038/s41422-020-0287-8 10.1016/j.cell.2020.12.040 10.1083/jcb.144.4.789 10.1186/1742-2094-9-77 10.1093/emboj/21.7.1505 10.1007/s00401-016-1545-1 10.3171/2014.7.JNS131644 10.1007/s00401-019-02008-w 10.1093/neuros/nyaa355 10.1158/1541-7786.MCR-11-0559 10.1158/2159-8290.CD-20-0160 10.1038/ng.3651 10.1007/s00401-019-02095-9 10.1186/s40478-020-01040-2 10.1093/neuonc/noaa226 10.1093/jnci/djv377 10.1093/neuonc/noy104 10.1093/neuonc/nox094 10.1007/s11060-019-03333-6 10.1038/s41586-020-03064-z 10.1038/s41586-020-03114-6 10.1038/s41586-020-03133-3 10.1007/s00401-020-02188-w 10.1038/nm0795-686 10.1016/j.ccell.2018.11.009 10.1093/neuonc/noz175.583 10.1093/neuonc/noab118 10.1038/onc.2009.416 10.1186/s13059-014-0503-2 10.1186/s13059-016-1066-1 10.1038/nature26000 10.1093/bioinformatics/btu170 10.1101/gr.213611.116 10.1038/s41587-019-0201-4 10.1093/bioinformatics/btt656 10.1038/labinvest.3700307 10.1016/j.cell.2016.11.048 10.7554/eLife.19760 10.1038/nbt.4096 10.1016/j.cell.2019.05.031 10.1186/s13059-019-1874-1 10.1038/s41592-019-0619-0
Nature Genetics; Choudhury A, Magill ST et. al.

May 10th, 2022 - Meningiomas are the most common primary intracranial tumors. There are no effective medical therapies for meningioma patients, and new treatments have been encumbered by limited understanding of meningioma biology. Here, we use DNA methylation pro...

see more →

Guidelines  1 results

Stereotactic Radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: Intern...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566438
Neurosurgery Marchetti M, Sahgal A et. al.

May 29th, 2020 - Stereotactic radiosurgery (SRS) for benign intracranial meningiomas is an established treatment. To summarize the literature and provide evidence-based practice guidelines on behalf of the International Stereotactic Radiosurgery Society (ISRS). Ar...

see more →

Clinicaltrials.gov  41 results

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors or Meningiomas Expressing SST2A
https://clinicaltrials.gov/ct2/show/NCT05278208

Apr 28th, 2022 - Somatostatin receptors regulate cell growth through downstream modulation of both proliferation and apoptosis signaling pathways, and thus represent a potential therapeutic target. Lutathera (Lutetium [Lu]177 Dotatate) is a radionuclide therapy wh...

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
https://clinicaltrials.gov/ct2/show/NCT02847559

Apr 22nd, 2022 - PRIMARY OBJECTIVES: I. To determine progression free survival (PFS) for 6 months (PFS-6) in patients with recurrent or progressive meningioma. SECONDARY OBJECTIVES: I. To determine overall survival (OS). II. To determine tumor response rate (TRR)....

Oncological Care for Patients With Meningioma
https://clinicaltrials.gov/ct2/show/NCT02973256

Apr 14th, 2022 - Meningiomas with malignant components include grade II meningiomas (GIIM, the most common ones) and grade III meningiomas (GIIIM). They represent 5-35% of all meningiomas. Histological diagnosis of GIIM criteria were changed in 2007 and might be v...

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
https://clinicaltrials.gov/ct2/show/NCT03604978

Apr 11th, 2022 - PRIMARY OBJECTIVES: I. To evaluate the maximum tolerated combination and safety profile of multi-fraction radiosurgery with concurrent nivolumab plus or minus ipilimumab for recurrent radiation-relapsed high-grade meningioma. (Phase I) II. To eval...

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
https://clinicaltrials.gov/ct2/show/NCT04158284

Mar 31st, 2022 - KRANIOPHARYNGEOM Registry 2019 will prospectively collect and descriptively analyse data on diagnostics, treatment, and follow-up of patients with craniopharyngioma. In continuation of preceding studies also patients with xanthogranuloma, meningio...

see more →

News  47 results

Brain Tumors Exact Higher Mortality Toll in Men Than Women
https://www.medscape.com/viewarticle/968594

Feb 15th, 2022 - New research shows that men in their 20s and 30s have worse survival from many different types of brain tumors than women of the same age. And, researchers say, it’s not exactly clear why. Differences in treatment may mediate some of the associati...

GI Cancer and Obesity: Fighting One Means Addressing the Other
https://www.medscape.com/viewarticle/959973

Oct 6th, 2021 - By 2030, it is projected that most Americans will be overweight, and of those, nearly 50% of adults will be obese. Although the majority of Americans are aware that obesity can have adverse health consequences, survey findings show that few are aw...

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 3rd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Meningioma May Be Tied to Dental X-Rays
https://www.onclive.com/view/meningioma-may-be-tied-to-dental-x-rays

Dec 5th, 2020 - Elizabeth B. Claus, MD New data suggest that dental x-rays obtained frequently at a young age may boost the risk of intracranial meningioma. Although dental x-rays are an important tool in well selected patients, efforts to moderate exposure to ...

Direct Targeting of RET Aberrations Moves Closer to the Clinic
https://www.onclive.com/view/direct-targeting-of-ret-aberrations-moves-closer-to-the-clinic

Dec 5th, 2020 - Alexander Drilon, MD Research on the proto-oncogene RET has accelerated exponentially since 1985, when Masahide Takahashi, MD, PhD, and colleagues first reported a fusion rearrangement in lymphoma DNA.1 Early progress was slow. Other investigator...

see more →

Patient Education  8 results see all →